BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16200579)

  • 1. Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis.
    Bryl E; Vallejo AN; Matteson EL; Witkowski JM; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2005 Oct; 52(10):2996-3003. PubMed ID: 16200579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of p38 MAP kinase in CD4+ lymphocytes by infliximab therapy in patients with rheumatoid arthritis.
    Garfield BE; Krahl T; Appel S; Cooper SM; Rincón M
    Clin Immunol; 2005 Aug; 116(2):101-7. PubMed ID: 15914087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy with infliximab decreases the CD4+CD28- T cell compartment in peripheral blood in patients with rheumatoid arthritis.
    Pawlik A; Ostanek L; Brzosko I; Brzosko M; Masiuk M; Machalinski B; Szklarz BG
    Rheumatol Int; 2004 Nov; 24(6):351-4. PubMed ID: 14504910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating NK-cell receptors co-stimulate CD4(+)CD28(-) T cells in patients with rheumatoid arthritis.
    Fasth AE; Björkström NK; Anthoni M; Malmberg KJ; Malmström V
    Eur J Immunol; 2010 Feb; 40(2):378-87. PubMed ID: 19904767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.
    Aeberli D; Seitz M; Jüni P; Villiger PM
    Rheumatology (Oxford); 2005 Feb; 44(2):172-5. PubMed ID: 15509629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface CD28 levels define four CD4+ T cell subsets: abnormal expression in rheumatoid arthritis.
    Salazar-Fontana LI; Sanz E; Mérida I; Zea A; Sanchez-Atrio A; Villa L; Martínez-A C; de la Hera A; Alvarez-Mon M
    Clin Immunol; 2001 May; 99(2):253-65. PubMed ID: 11318597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo homeostatic proliferation of CD4+ T cells in rheumatoid arthritis is dysregulated and driven by membrane-anchored TNFalpha.
    Wagner U; Pierer M; Wahle M; Moritz F; Kaltenhäuser S; Häntzschel H
    J Immunol; 2004 Aug; 173(4):2825-33. PubMed ID: 15295001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFα promotes Th17 cell differentiation through IL-6 and IL-1β produced by monocytes in rheumatoid arthritis.
    Zheng Y; Sun L; Jiang T; Zhang D; He D; Nie H
    J Immunol Res; 2014; 2014():385352. PubMed ID: 25436214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients.
    Gerli R; Schillaci G; Giordano A; Bocci EB; Bistoni O; Vaudo G; Marchesi S; Pirro M; Ragni F; Shoenfeld Y; Mannarino E
    Circulation; 2004 Jun; 109(22):2744-8. PubMed ID: 15159291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of CD4(+)CD28null T lymphocytes by tumor necrosis factor-alpha blockade in patients with unstable angina.
    Rizzello V; Liuzzo G; Brugaletta S; Rebuzzi A; Biasucci LM; Crea F
    Circulation; 2006 May; 113(19):2272-7. PubMed ID: 16682617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.
    Toubi E; Kessel A; Mahmudov Z; Hallas K; Rozenbaum M; Rosner I
    Ann N Y Acad Sci; 2005 Jun; 1051():506-14. PubMed ID: 16126991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor receptor type I expression of CD4+ T cells in rheumatoid arthritis enables them to follow tumor necrosis factor gradients into the rheumatoid synovium.
    Rossol M; Schubert K; Meusch U; Schulz A; Biedermann B; Grosche J; Pierer M; Scholz R; Baerwald C; Thiel A; Hagen S; Wagner U
    Arthritis Rheum; 2013 Jun; 65(6):1468-76. PubMed ID: 23494522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes.
    Kirino Y; Takeno M; Murakami S; Kobayashi M; Kobayashi H; Miura K; Ideguchi H; Ohno S; Ueda A; Ishigatsubo Y
    Arthritis Rheum; 2007 Feb; 56(2):464-75. PubMed ID: 17265482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis.
    Colin EM; Asmawidjaja PS; van Hamburg JP; Mus AM; van Driel M; Hazes JM; van Leeuwen JP; Lubberts E
    Arthritis Rheum; 2010 Jan; 62(1):132-42. PubMed ID: 20039421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
    Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA
    Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis.
    Belostocki K; Pricop L; Redecha PB; Aydin A; Leff L; Harrison MJ; Salmon JE
    Arthritis Rheum; 2008 Feb; 58(2):384-8. PubMed ID: 18240208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-15 selectively expands CD57+ CD28- CD4+ T cells, which are increased in active rheumatoid arthritis.
    Yamada H; Kaibara N; Okano S; Maeda T; Shuto T; Nakashima Y; Okazaki K; Iwamoto Y
    Clin Immunol; 2007 Sep; 124(3):328-35. PubMed ID: 17644042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFα polymorphism as marker of immunosenescence for rheumatoid arthritis patients.
    Rodríguez-Carrio J; Alperi-López M; López P; Alonso-Castro S; Ballina-García FJ; Suárez A
    Exp Gerontol; 2015 Jan; 61():123-9. PubMed ID: 25510954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis.
    Groh V; Bruhl A; El-Gabalawy H; Nelson JL; Spies T
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9452-7. PubMed ID: 12878725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.